MRAbit
MRAbit
Authorised
- Alarelin
Product identification
Medicine name:
MRAbit
Active substance:
- Alarelin
Target species:
-
Rabbit (female for reproduction)
Route of administration:
-
Vaginal use
Product details
Active substance and strength:
-
Alarelin1.50/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for vaginal solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH01CA
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Package description:
- cardboard box with 5 sachets of 4 g (210 doses)
- cardboard box with 5 sachets of 12 g (630 doses)
- cardboard box with 5 sachets of 40 g (2.100 doses)
- cardboard box with 25 sachets of 4 g (210 doses)
- cardboard box with 25 sachets de12 g ( 630 doses)
- cardboard box with 25 sachets of 40 g (2.100 doses)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Kubus Lab S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Kubus Lab S.A.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 1361/01/20DFVPT
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0286/001
Concerned member states:
-
Italy
-
Portugal
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
